Shopping Cart
Remove All
Your shopping cart is currently empty
Biosynthesis of LTA3 occurs from 5,8,11-eicosatrienoic acid via the 5-LO pathway and it is the putative intermediate in the biosynthesis of 3-series leukotrienes. LTA3 as a free acid is highly unstable. The methyl ester is stable and can be readily hydrolyzed to the free acid as needed.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 μg | $383 | 35 days | 35 days |
| Description | Biosynthesis of LTA3 occurs from 5,8,11-eicosatrienoic acid via the 5-LO pathway and it is the putative intermediate in the biosynthesis of 3-series leukotrienes. LTA3 as a free acid is highly unstable. The methyl ester is stable and can be readily hydrolyzed to the free acid as needed. |
| Molecular Weight | 334.49 |
| Formula | C21H34O3 |
| Cas No. | 83851-38-1 |
| Relative Density. | 0.985g/cm3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | PBS (pH 7.2): >1 mg/mL (from 13(S)-HODE), Sonication is recommended. DMSO: >50 mg/mL (per Rao Maddipati), Sonication is recommended. Ethanol: >50 mg/mL (per Rao Maddipati), Sonication is recommended. DMF: >50 mg/mL (per Rao Maddipati), Sonication is recommended. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.